Stanford’s ViRx and Fifty1 AI Labs Forge Alliance to Repurpose Drugs for Pandemic Preparedness

ViRx@Stanford, a leading biosecurity and pandemic preparedness initiative, and Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), an innovati...

August 25, 2025 | Monday | News
Terumo Acquires OrganOx in $1.5 Billion Deal to Transform Global Organ Transplantation

- Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine - Terumo Corporation announced ...

August 25, 2025 | Monday | News
PathAI and Moffitt Cancer Center Launch Strategic Collaboration to Shape the Future of Cancer Care

PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospi...

August 22, 2025 | Friday | News
Thermo Fisher Opens Carbon-Neutral Manufacturing Center in North Carolina to Boost U.S. Pipette Tip Supply

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the grand opening of its innovative manufacturing center of excellenc...

August 22, 2025 | Friday | News
Agilent MMR IHC Panel pharmDx Wins FDA Approval as Companion Diagnostic for Colorectal Cancer

-Agilent Technologies Inc. announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for ...

August 21, 2025 | Thursday | News
Tivic Health Acquires Entolimod™ INDs to Advance ARS and Cancer Trials

INDs Transferred from Statera Biopharma Advance Entolimod for ARS Along Regulatory Pathway and Enable Pursuit of Clinical Trial Program in Neutropenia ...

August 21, 2025 | Thursday | News
BioSkryb Genomics Secures Exclusive License for Stanford and CZ Biohub SF Innovation in Single-Cell Methylation and Variant Analysis

The licensed IP enables genome-wide methylation and variant analyses in the same single cells or ultra-low input samples BioSkryb Genomics, a ...

August 21, 2025 | Thursday | News
XtalPi and Dong-A ST Sign MOU to Co-Develop Next-Generation Therapies for Immunology and Inflammation

XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop...

August 20, 2025 | Wednesday | News
Idorsia’s TRYVIO™ Included in New ACC/AHA Hypertension Guidelines as a Novel Treatment Option

Idorsia Ltd (SIX: IDIA) announces that its novel dual endothelin receptor antagonist (ERA), TRYVIO™ (aprocitentan), has been included in the new co...

August 20, 2025 | Wednesday | News
Qihan Biotech Receives FDA Clearance to Begin U.S. Trial of Universal CAR-T Therapy for Refractory Lupus

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to...

August 19, 2025 | Tuesday | News
Atropos Health and Novartis Partner to Harness AI for Faster Rare Disease Diagnosis

-Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, announced a collaboration wit...

August 19, 2025 | Tuesday | News
Ryght AI and Biorasi Partner to Transform Clinical Trial Feasibility with AI Digital Twins

Ryght AI, the clinical trials AI technology company transforming site activation and optimization through AI digital twins of every research site in the ...

August 18, 2025 | Monday | News
Regen BioPharma Advances HemaXellerate Toward Phase 1 Trials Following FDA Clearance

Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company&...

August 18, 2025 | Monday | News
Ascentage Pharma Receives FDA and EMA Clearance for Global Phase III Trial of Lisaftoclax in Higher-Risk MDS

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and c...

August 18, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close